AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21953275 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib
Number of subjects: 31
Study 18468289 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 5
Study 18468289 — intervention group
Group type: COMPARATOR
Intervention: Social reinforcement (playing with friends)
Number of subjects: 5
Study 18468289 — intervention group
Group type: COMPARATOR
Intervention: Alone play
Number of subjects: 5
Study 18468289 — intervention group
Group type: COMPARATOR
Intervention: Quiet time (resting)
Number of subjects: 5
Study 16636492 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PPV)
Number of subjects: 26
Study 16636492 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 12005141 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% chlorhexidine digluconate mouthrinse
Number of subjects: 20
Study 12005141 — intervention group
Group type: COMPARATOR
Intervention: Sterile water mouthrinse
Number of subjects: 20
Study 10509320 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary combined‐modality therapy
Number of subjects: 0
Study 10509320 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 10509320 — intervention group
Group type: COMPARATOR
Intervention: Preoperative combined‐modality therapy
Number of subjects: 0
Study 10509320 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of radiation (INT 0123 trial)
Number of subjects: 0
Study 7595900 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 1819290 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrush/paste
Number of subjects: 120
Study 1819290 — intervention group
Group type: EXPERIMENTAL
Intervention: Massularia acuminata chewing stick
Number of subjects: 120
Study 1819290 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorindeia warneckei chewing stick
Number of subjects: 120
Study 1819290 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study 6637554 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypospadiacs
Number of subjects: 33
Study 6637554 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 33
Study 31771594 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent HPV16 infection
Number of subjects: 0
Study 31771594 — intervention group
Group type: EXPERIMENTAL
Intervention: Sum of viral load for all hrHPV types
Number of subjects: 0
Study 31771594 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent HPV16 infection with CIN2+
Number of subjects: 0
Study 31771594 — intervention group
Group type: COMPARATOR
Intervention: Persistent infection without CIN2+ lesions
Number of subjects: 0
Study 31771594 — intervention group
Group type: EXPERIMENTAL
Intervention: Sum of all hrHPV types with persistent infection and CIN2+
Number of subjects: 0
Study 31771594 — intervention group
Group type: COMPARATOR
Intervention: Sum of all hrHPV types without CIN2+
Number of subjects: 0
Study 31006680 — intervention group
Group type: EXPERIMENTAL
Intervention: Drought driven food insecurity assessment
Number of subjects: 422
Study 31006680 — intervention group
Group type: EXPERIMENTAL
Intervention: Malnutrition assessment in under five children
Number of subjects: 422
Study 31006680 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status assessment
Number of subjects: 422
Study 29020106 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi training for 6 months
Number of subjects: 87
Study 29020106 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 87
Study 29020106 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi experts
Number of subjects: 87
Study 25383451 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 378
Study 25383451 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 378
Study 23524528 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT plus implantable cardioverter defibrillator
Number of subjects: 1820
Study 23524528 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator-only
Number of subjects: 1820
Study 23524528 — intervention group
Group type: EXPERIMENTAL
Intervention: Every 5-point increase in RV fractional area change
Number of subjects: 1820
Study 23524528 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline tricuspid regurgitant velocity
Number of subjects: 1820
Study 21816056 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic combination (Bifidobacterium infantis, Streptococcus thermophilus and Bifidobacterium lactis)
Number of subjects: 1100
Study 19346565 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated HIV primary care, mental health, and substance abuse services
Number of subjects: 431
Study 19346565 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (control group)
Number of subjects: 431
Study 19346565 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated interventions
Number of subjects: 431
Study 16776026 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordination model
Number of subjects: 28
Study 15476990 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based education package (information booklet and verbal teaching by a urology nurse)
Number of subjects: 55
Study 15476990 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education package)
Number of subjects: 55
Study 11293750 — intervention group
Group type: EXPERIMENTAL
Intervention: New method of rapid dilation using a stiffenable metal guide wire of 6.6 Fr and plastic bougies
Number of subjects: 60
Study 11293750 — intervention group
Group type: COMPARATOR
Intervention: Conventional percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 60
Study 11293750 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (new method and conventional approach)
Number of subjects: 60
Study 9385482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparfloxacin 400 mg orally once followed by 200 mg orally daily for 10 days (n = 168)
Number of subjects: 330
Study 9385482 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor 500 mg orally every 8 hours for 10 days (n = 162)
Number of subjects: 330
Study 9385482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sparfloxacin and Cefaclor
Number of subjects: 330
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low dose rate iridium implants following 50 Gy whole breast irradiation
Number of subjects: 404
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 404
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-60 beams
Number of subjects: 404
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 404
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical T-size over 20 mm
Number of subjects: 404
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up period
Number of subjects: 404
Study 7961014 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose rate (mean 0.57, range 0.26-0.89 Gy/h)
Number of subjects: 404
Study 3036020 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg
Number of subjects: 12
Study 3036020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30615583 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga-based lifestyle intervention (including diet)
Number of subjects: 260
Study 30615583 — intervention group
Group type: COMPARATOR
Intervention: Dietary intervention
Number of subjects: 260
Study 28891367 — intervention group
Group type: EXPERIMENTAL
Intervention: Foeniculum vulgare (fennel)
Number of subjects: 60
Study 28891367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 27746539 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg intrathecal levobupivacaine with 25 μg fentanyl followed by epidural top‐ups of 14 ml of levobupivacaine 0.125% with fentanyl 30 μg
Number of subjects: 60
Study 27746539 — intervention group
Group type: COMPARATOR
Intervention: 4 mg intrathecal ropivacaine with 25 μg fentanyl followed by epidural top‐ups of 14 ml of ropivacaine 0.2% with fentanyl 30 μg
Number of subjects: 60
Study 24048718 — intervention group
Group type: EXPERIMENTAL
Intervention: IV fluid guided by stroke volume (SV)
Number of subjects: 135
Study 24048718 — intervention group
Group type: COMPARATOR
Intervention: IV fluid guided by central venous pressure (CVP)
Number of subjects: 135
Study 23908479 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-treated zoster vaccine (ZVHT)
Number of subjects: 0
Study 23908479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20181456 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-Being Therapy (WBT)
Number of subjects: 162
Study 20181456 — intervention group
Group type: COMPARATOR
Intervention: Anxiety Management (AM)
Number of subjects: 162
Study 20181456 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological Well-Being Scales (PWB)
Number of subjects: 162
Study 20181456 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom Questionnaire (SQ)
Number of subjects: 162
Study 20181456 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised Children's Manifest Anxiety Scale (RCMAS)
Number of subjects: 162
Study 18208424 — intervention group
Group type: EXPERIMENTAL
Intervention: The '11' exercise program (15-min program consisting of ten exercises for core stability, lower extremity strength, balance and agility)
Number of subjects: 34
Study 18208424 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study 17002045 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant SUMS‐1 (n = 38)
Number of subjects: 110
Study 17002045 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant enterosgel (n = 37)
Number of subjects: 110
Study 17002045 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 35)
Number of subjects: 110
Study 12779268 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferoxamine (DF)
Number of subjects: 72
Study 12779268 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (L1)
Number of subjects: 72
Study 12779268 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferoxamine (DF) and Deferiprone (L1)
Number of subjects: 72
Study 10950766 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir (IDV)
Number of subjects: 89
Study 10950766 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir soft-gel capsules (SQVsgc)
Number of subjects: 89
Study 10950766 — intervention group
Group type: COMPARATOR
Intervention: Saquinavir hard capsules (SQVhc)
Number of subjects: 89
Study 8979093 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 25
Study 8979093 — intervention group
Group type: COMPARATOR
Intervention: No antihypertensive therapy
Number of subjects: 25
Study 1468245 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg sodium hyaluronate in 2 ml phosphate buffer for 5 weeks
Number of subjects: 40
Study 1468245 — intervention group
Group type: COMPARATOR
Intervention: 20 mg sodium hyaluronate in 2 ml phosphate buffer for 5 weeks + 0.4 mg dexamethasone phosphate
Number of subjects: 40
Study 373254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tagamet (cimetidine) 1 g daily (3x200 mg after meal and 400 mg in the evening) for 20 days
Number of subjects: 25
Study 373254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tagamet (cimetidine)
Number of subjects: 25
Study 31619065 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed hard palate closure (at age 36 months)
Number of subjects: 122
Study 31619065 — intervention group
Group type: COMPARATOR
Intervention: Early hard palate closure (at age 12 months)
Number of subjects: 122
Study 31727085 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercise programme
Number of subjects: 64
Study 31727085 — intervention group
Group type: COMPARATOR
Intervention: General exercise programme
Number of subjects: 64
Study 27834670 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with instability (RTI)
Number of subjects: 37
Study 27834670 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 37
Study 27834670 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 37
Study 26501125 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone consultation
Number of subjects: 86
Study 26501125 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face consultation
Number of subjects: 86
Study 23932494 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR2 polymorphisms (specifically A allele of rs1256049)
Number of subjects: 3799
Study 23932494 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR2 polymorphisms (specifically A allele of rs4986938)
Number of subjects: 3799
Study 23932494 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR1 polymorphisms (rs2234693 and rs9340799)
Number of subjects: 3799
Study 22143987 — intervention group
Group type: EXPERIMENTAL
Intervention: High negative Lindenmayer scores
Number of subjects: 126
Study 22143987 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium negative Lindenmayer scores
Number of subjects: 126
Study 22143987 — intervention group
Group type: EXPERIMENTAL
Intervention: Low negative Lindenmayer scores
Number of subjects: 126
Study 19839254 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (n = 74) underwent septoplasty with transseptal suturing, and conchotomy with glue as a haemostatic.
Number of subjects: 146
Study 19839254 — intervention group
Group type: COMPARATOR
Intervention: Group II (n = 72) underwent septoplasty and conchotomy with glue as a haemostatic as well as septal cartilage and mucoperichodrial flaps sealant (no transseptal suturing).
Number of subjects: 146
Study 17080754 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional hazards (PH) model
Number of subjects: 0
Study 17080754 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated failure time (AFT) model
Number of subjects: 0
Study 15633195 — intervention group
Group type: EXPERIMENTAL
Intervention: BRCA1/2 testing (n = 181, 85%)
Number of subjects: 212
Study 15633195 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered counseling intervention
Number of subjects: 212
Study 15633195 — intervention group
Group type: COMPARATOR
Intervention: Non-testers (those who declined testing)
Number of subjects: 212
Study 12784116 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex
Number of subjects: 0
Study 12784116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12784116 — intervention group
Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 0
Study 10441812 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 737
Study 10441812 — intervention group
Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 737
Study 7877646 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant combination chemotherapy (cyclophosphamide, methotrexate, and fluorouracil) for 12 monthly cycles
Number of subjects: 386
Study 7877646 — intervention group
Group type: COMPARATOR
Intervention: No further treatment after radical mastectomy
Number of subjects: 386
Study 2172161 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril (20 mg once or 5 mg four times at 6-hour intervals)
Number of subjects: 9
Study 2172161 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg)
Number of subjects: 9
Study 2172161 — intervention group
Group type: COMPARATOR
Intervention: In vitro assays using Z-Phe-His-Leu as substrate
Number of subjects: 9
Study 2172161 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma angiotensin II
Number of subjects: 9
Study 2172161 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma angiotensin II to angiotensin I ratio
Number of subjects: 9
Study 398480 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 55
Study 398480 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin
Number of subjects: 55
Study 29092038 — intervention group
Group type: COMPARATOR
Intervention: PVAC ablation
Number of subjects: 0
Study 29092038 — intervention group
Group type: COMPARATOR
Intervention: nMARQ ablation
Number of subjects: 0
Study 29092038 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ablation
Number of subjects: 0
Study 29092038 — intervention group
Group type: COMPARATOR
Intervention: Catheter ablation (PVAC and nMARQ combined)
Number of subjects: 0
Study 28578163 — intervention group
Group type: EXPERIMENTAL
Intervention: SAC urinary catheter (experimental group)
Number of subjects: 489
Study 28578163 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter (control group)
Number of subjects: 489
Study 24554463 — intervention group
Group type: EXPERIMENTAL
Intervention: DQ‐MA imaging with τ = 3 ms
Number of subjects: 5
Study 24554463 — intervention group
Group type: EXPERIMENTAL
Intervention: DQ‐MA imaging with 1 or 2 averages
Number of subjects: 5
Study 24554463 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher nominal resolution DQ‐MA imaging
Number of subjects: 5
Study 24554463 — intervention group
Group type: EXPERIMENTAL
Intervention: DQ‐MA sequence
Number of subjects: 5
Study 23818692 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.36 g L-carnitine + 80 g carbohydrate (Carnitine)
Number of subjects: 12
Study 23818692 — intervention group
Group type: COMPARATOR
Intervention: 80 g carbohydrate (Control)
Number of subjects: 12
Study 21437714 — intervention group
Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg
Number of subjects: 133
Study 21437714 — intervention group
Group type: COMPARATOR
Intervention: almotriptan 12.5 mg
Number of subjects: 133
Study 18822917 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium ferulate
Number of subjects: 82
Study 18822917 — intervention group
Group type: COMPARATOR
Intervention: Conventional liver protecting therapy (Control)
Number of subjects: 82
Study 15899709 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 1
Study 12950604 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (omeprazole 4 x 40 mg and amoxicillin 4 x 750 mg for 14 days)
Number of subjects: 84
Study 12950604 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (omeprazole 2 x 20 mg, bismuthcitrate 4 x 107 mg, metronidazole 4 x 500 mg and tetracycline 4 x 500 mg for 14 days)
Number of subjects: 84
Study 10370394 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CAD
Number of subjects: 22
Study 10370394 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 22
Study 8829931 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal inhalation of sevoflurane 5%
Number of subjects: 20
Study 8829931 — intervention group
Group type: COMPARATOR
Intervention: Oral inhalation of sevoflurane 5%
Number of subjects: 20
Study 2068468 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin (600 mg) plus aztreonam (1 g)
Number of subjects: 138
Study 2068468 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin (600 mg) plus gentamicin (80 mg)
Number of subjects: 138
Study 7048482 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 604
Study 7048482 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin + Dipyridamole
Number of subjects: 604
Study 7048482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 604
Study 31286694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal high flow (NHF) at 2, 4, and 6 L/min
Number of subjects: 24
Study 31286694 — intervention group
Group type: COMPARATOR
Intervention: Bubble CPAP
Number of subjects: 24
Study 29214975 — intervention group
Group type: EXPERIMENTAL
Intervention: HomeHealth intervention
Number of subjects: 51
Study 29214975 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 51
Study 29214975 — intervention group
Group type: COMPARATOR
Intervention: NHS and carer support costs
Number of subjects: 51
Study 26022434 — intervention group
Group type: EXPERIMENTAL
Intervention: RCA plus low-dose dalteparin
Number of subjects: 53
Study 26022434 — intervention group
Group type: COMPARATOR
Intervention: RCA only
Number of subjects: 53
Study 26022434 — intervention group
Group type: COMPARATOR
Intervention: Normal-dose dalteparin
Number of subjects: 53
Study 26022434 — intervention group
Group type: COMPARATOR
Intervention: RCA only, Normal-dose dalteparin
Number of subjects: 53
Study 24424707 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 2.5 mg
Number of subjects: 457
Study 24424707 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg
Number of subjects: 457
Study 24424707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 22498720 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Blood Pressure Telemonitoring and Case Management (TI)
Number of subjects: 450
Study 22498720 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 450
Study 19528889 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (30 periods)
Number of subjects: 30
Study 19528889 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 30
Study 17478880 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied heparin spraygel
Number of subjects: 0
Study 17478880 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (peroral analgesics or nonsteroidal anti‐inflammatory drugs, elastic stockings, mild ambulation)
Number of subjects: 0
Study 15111231 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetrical stimuli
Number of subjects: 0
Study 15111231 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetrical stimuli
Number of subjects: 0
Study 12815777 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacron (0.15 mg/kg)
Number of subjects: 20
Study 12815777 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacron (0.1 mg/kg)
Number of subjects: 20
Study 12815777 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium chloride
Number of subjects: 20
Study 12815777 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacron
Number of subjects: 20
Study 9274466 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralfate 1 g four times daily
Number of subjects: 24
Study 9274466 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralfate 2 g twice daily
Number of subjects: 24